- Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma
Hyeyoon Chang et al, 2015, Annals of Diagnostic Pathology CrossRef - EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic Gastric Adenocarcinoma
Ann-Katrin Piper et al, 2024, International Journal of Molecular Sciences CrossRef - Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy
L Liang et al, 2016, Oncogene CrossRef - Current Strategies for Pharmacokinetic Optimization
Uli Binder et al, 2015, Biobetters CrossRef - Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
Zeren Sun et al, 2024, Journal of Medicinal Chemistry CrossRef - MicroRNA-195 inhibits human gastric cancer by directly targeting basic fibroblast growth factor
J. Wang et al, 2017, Clinical and Translational Oncology CrossRef - Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models
Meghan Grojean et al, 2021, Journal of Cellular and Molecular Medicine CrossRef - Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways
Haiyong Wang et al, 2017, BMC Cancer CrossRef - Characterization of human gastric adenocarcinoma cell lines established from peritoneal ascites
Bożenna Mytar et al, 2018, Oncology Letters CrossRef - Predictive biomarkers in gastric cancer
C. Röcken, 2023, Journal of Cancer Research and Clinical Oncology CrossRef - The challenge of developmental therapeutics for adrenocortical carcinoma
Ricardo Costa et al, 2016, Oncotarget CrossRef - Mucin 20 modulates proteasome capacity through c‐Met signalling to increase carfilzomib sensitivity in mantle cell lymphoma
Xiaobin Wang et al, 2021, Journal of Cellular and Molecular Medicine CrossRef - ESM1 Interacts with c-Met to Promote Gastric Cancer Peritoneal Metastasis by Inducing Angiogenesis
Jiaoyang Yang et al, 2023, Cancers CrossRef - Autophagy is required for crizotinib-induced apoptosis in MET-amplified gastric cancer cells
Rebecca D. Schroeder et al, 2017, Oncotarget CrossRef - Co-targeting c-Met and DNA double-strand breaks (DSBs): Therapeutic strategies in BRCA-mutated gastric carcinomas
Chrysovalantou Mihailidou et al, 2017, Biochimie CrossRef - MET in gastric cancer – discarding a 10% cutoff rule
Marie‐Luise Metzger et al, 2016, Histopathology CrossRef - Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer
Jun Lu et al, 2015, Journal of Translational Medicine CrossRef - Molecular Mechanisms in Gastric Carcinogenesis
Jonathan Cools-Lartigue et al, 2015, Gastric Cancer CrossRef - FGFR and inhibitors
Xiaokun Li, 2024, Fibroblast Growth Factors CrossRef - Downregulation of c-Met expression does not enhance the sensitivity of gastric cancer cell line MKN-45 to gefitinib
JIN-AN MA et al, 2015, Molecular Medicine Reports CrossRef - Electrostatic explanation of D1228V/H/N-induced c-Met resistance and sensitivity to type I and type II kinase inhibitors in targeted gastric cancer therapy
Zhen Xu et al, 2019, Journal of Molecular Modeling CrossRef - Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity
Tianwei Zhang et al, 2015, PLOS ONE CrossRef - Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target
Maria Trovato et al, 2017, Biomarker Insights CrossRef - Peptidomimetic suppresses proliferation and invasion of gastric cancer cells by fibroblast growth factor 2 signaling cascade blockage
Wulan Li et al, 2016, Anti-Cancer Drugs CrossRef